Clinical trial
Assessment of the Optimal Timing of Chemotherapy With or After ATRA and the Role of Maintenance
NCT00599937 is registered in ClinicalTrials.gov with Groupe d'etude et de travail sur les leucemies aigues promyelocytaires as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of the Optimal Timing of Chemotherapy With or After ATRA and the Role of Maintenance
- Lead sponsor
- Groupe d'etude et de travail sur les leucemies aigues promyelocytaires
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 31, 1993
- Completion date
- December 31, 1998
- Enrollment
- 576 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.